Our data showed that five (NET1, KCNK1, MAL2, PLS1, and PLS3) of these 16 DEGs were associated with poor overall survival (OS) in PDA patients (Fig. 6A, C, E, G, and I). This evidence concerns the gene PLS3 and Patent ductus arteriosus.